These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17068638)

  • 1. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Sep; 96(9):758-60. PubMed ID: 17068638
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of generic alendronate in the treatment of osteoporosis.
    National Osteoporosis Foundation of South Africa
    S Afr Med J; 2006 Aug; 96(8):696-7. PubMed ID: 17019490
    [No Abstract]   [Full Text] [Related]  

  • 3. Generic alendronate in the treatment of osteoporosis.
    Kanfer I
    S Afr Med J; 2006 Oct; 96(10):1008-10. PubMed ID: 17164925
    [No Abstract]   [Full Text] [Related]  

  • 4. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Dec; 96(12):1214. PubMed ID: 17252142
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].
    MMW Fortschr Med; 2005 Dec; 147(49-50):74-5. PubMed ID: 16401016
    [No Abstract]   [Full Text] [Related]  

  • 6. NOFSA statement on generic bisphosphonates.
    de Jongh JN
    S Afr Med J; 2006 Nov; 96(11):1138. PubMed ID: 17167690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 8. The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis.
    Landfeldt E; Ström O
    Bone; 2012 Oct; 51(4):637-42. PubMed ID: 22842329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in the treatment of osteoporosis.
    Poole KE; Compston JE
    BMJ; 2012 May; 344():e3211. PubMed ID: 22619192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Generic preparations--undocumented effects?].
    Høiseth A
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2985-6; author reply 2986. PubMed ID: 17117201
    [No Abstract]   [Full Text] [Related]  

  • 12. [Generic preparations--undocumented effects?].
    Dyrkorn R
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2548; author reply 2548. PubMed ID: 17028644
    [No Abstract]   [Full Text] [Related]  

  • 13. A reappraisal of generic bisphosphonates in osteoporosis.
    Kanis JA; Reginster JY; Kaufman JM; Ringe JD; Adachi JD; Hiligsmann M; Rizzoli R; Cooper C
    Osteoporos Int; 2012 Jan; 23(1):213-21. PubMed ID: 21953472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of alendronate on glucocorticoid-induced osteoporosis].
    Zou X; Li Q; Shi C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
    Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
    An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone density measurements after alendronate therapy?].
    Schoppmeyer M
    Med Monatsschr Pharm; 2015 May; 38(5):196-7; discussion 197. PubMed ID: 26364412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence of alendronate treatment for osteoporosis].
    Harada A
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():337-43. PubMed ID: 18161127
    [No Abstract]   [Full Text] [Related]  

  • 19. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 20. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.